Karim Lekadir has joined the newly established International Alliance for Personalised Medicine (IPM Alliance), a global initiative dedicated to accelerating the real-world adoption of precision and personalised medicine across healthcare systems worldwide.
The IPM Alliance brings together policymakers, clinicians, health systems, researchers, patients, and industry leaders to bridge the gap between scientific innovation and clinical implementation. Its mission is to ensure that advances in personalised medicine translate into accessible, equitable, and effective care for patients across countries and healthcare settings.
The creation of the IPM Alliance marks a significant evolution in the global personalised medicine landscape. Emerging from years of international collaboration through the International Center for Precision Cancer Medicine (ICPC), the Alliance expands the focus of precision medicine beyond oncology toward a broader and more integrated healthcare vision.
As part of this new chapter, the IPM Alliance will address six major disease areas:
- Oncology
- Cardiology
- Neurology
- Eye diseases
- Cardiometabolic diseases
- Rare diseases
Through policy development, healthcare readiness assessment, and international collaboration, the Alliance aims to move personalised medicine “from promise to practice.”
Karim Lekadir, ICREA Research Professor and Director of the BCN-AIM Lab at the Universitat de Barcelona, joins a distinguished international network of experts and leaders contributing to this mission. His expertise in trustworthy artificial intelligence, medical imaging, and AI implementation in healthcare aligns closely with the Alliance’s goal of enabling scalable, responsible, and patient-centered innovation.
The announcement comes ahead of the official launch of the IPM Alliance during the World Health Assembly in Geneva, followed by the launch of the Oncology Pillar during the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Reflecting on the initiative, the Alliance describes this moment not simply as the creation of a new organisation, but as the continuation and expansion of a growing global movement to transform healthcare through personalised medicine.
Follow the IMP Alliance on LinkedIn.